Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?
Introduction: We present a case of anion gap euglycemic diabetic ketoacidosis (EuDKA) in a patient with COVID-19 infection. Patients with diabetes mellitus are at increased risk of severe illness, and hyperglycaemia is associated with higher morbidity and mortality in patients infected with COVID-19...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SMC MEDIA SRL
2024-02-01
|
| Serie: | European Journal of Case Reports in Internal Medicine |
| Soggetti: | |
| Accesso online: | https://www.ejcrim.com/index.php/EJCRIM/article/view/4282 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|